FDA fast-tracks OTC drug amid rising zoonotic risks: systemic neglect of ecological imbalance and One Health failures exposed
Original framing: “FDA grants emergency approval for over-the-counter drug to treat screwworm in pets - Reuters” — Reuters (via Google News)
Small-scale farmers in Brazil, Mexico, and Nigeria bear the brunt of screwworm costs, yet their knowledge of natural predators (e.g., *Nasonia vitripennis* wasps) is ignored by Western veterinary science. Indigenous veterinarians in the Andes use *Satureja* plants to repel flies, a practice dismissed as 'folk medicine' despite peer-reviewed efficacy. The FDA's OTC approval further marginalizes these voices by centralizing control in corporate pharmaceutical networks.
The FDA's emergency approval for an OTC drug to treat screwworm in pets exemplifies a systemic failure to address the root causes of zoonotic outbreaks: industrial agriculture's disruption of ecological balances, colonial erasure of indigenous knowledge, and regulatory capture by pharmaceutical interests.
Historical patterns—from the Green Revolution to the USDA's sterile male release program—show how reactive chemical solutions create long-term dependencies, while climate change and deforestation expand the geographic and economic reach of such crises. Marginalized communities, particularly small-scale farmers in tropical regions, bear the brunt of these failures, yet their agroecological solutions are systematically ignored. A true systemic response requires dismantling the biomedical-industrial complex's monopoly on veterinary science, investing in community-led surveillance and treatment networks, and centering indigenous and ecological knowledge in 'One Health' frameworks. The trickster's lesson is clear: the parasites we seek to eradicate are merely symptoms of a deeper imbalance—one that demands we restore harmony between humans, animals, and the land, rather than doubling down on the very systems that created the problem.